HMOX1 and Alzheimer disease: Considering that the enhancement of HO-1 reduces the development of AD skin lesions in mice21, and caffeic acid is not cytotoxic under experimental conditions up to high concentration (1 mM)22, CA-PH may be a therapeutic candidate to improve AD phenotypes.